Buscar
Mostrando ítems 11-20 de 584
Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment
(2009-03-01)
PURPOSE: Subclinical inflammation may be observed in patients using topical antiglaucomatous drugs. The objective of this study was to investigate inflammation in conjunctiva of glaucoma patients using prostaglandin analogs, ...
Immunohistochemical expression of HLA-DR in the conjunctiva of patients under topical prostaglandin analogs treatment
(2009-03-01)
PURPOSE: Subclinical inflammation may be observed in patients using topical antiglaucomatous drugs. The objective of this study was to investigate inflammation in conjunctiva of glaucoma patients using prostaglandin analogs, ...
Two-dimensional transport analysis of transdermal drug absorption with a non-perfect sink boundary condition at the skin-capillary interface
(ELSEVIER SCIENCE INC, 2013-07-01)
A transient percutaneous drug absorption model was solved in two dimensions. Clearance of the topically-applied pharmaceutical occured at the skin-capillary boundary. Timolol penetration profiles in the dermal tissue were ...
Release of formaldehyde by 4 endodontic sealers
(1999-12-01)
Objective. The purpose of this study was to evaluate the release of formaldehyde by some root canal filling materials. Study design. Two older endodontic sealers, AH 26 and Endomethasone, and 2 recently available sealers, ...
Release of formaldehyde by 4 endodontic sealers
(1999-12-01)
Objective. The purpose of this study was to evaluate the release of formaldehyde by some root canal filling materials. Study design. Two older endodontic sealers, AH 26 and Endomethasone, and 2 recently available sealers, ...
Nanodrug Delivery Systems for Dermal and Transdermal Photosensitizer Drugs
(2017-03-29)
Skin is the largest organ in the human body and functions as a protective barrier. Molecules can penetrate the skin by three main routes: (1) intracellular (across the corneocytes), (2) intercellular lipids, and (3) ...